Presentation is loading. Please wait.

Presentation is loading. Please wait.

TAVR Medtronic CoreValve® Subclavian Approach Clinical Data

Similar presentations


Presentation on theme: "TAVR Medtronic CoreValve® Subclavian Approach Clinical Data"— Presentation transcript:

1 TAVR Medtronic CoreValve® Subclavian Approach Clinical Data
Carlos E. Ruiz M.D., Ph.D., FACC Director, Congenital, Valvular and Structural Heart Disease Program North Shore Long Island Jewish System Lenox Hill Heart and Vascular Institute of New York

2 Subclavian/Axillary: Right or Left
Access Routes Most appropriate access route selected by MDT based on patient anatomical characteristics Direct Aortic Transfemoral Subclavian Right Antererior Minithoracotomy Upper Ministernotomy Subclavian/Axillary: Right or Left Left preferred (versus right) due to delivery pathway’s typically better alignment with native aortic valve anatomy and less obstructive interaction with cranial perfusion

3 Access Selection Criteria
Subclavian artery luminal diameter and calcification Presence of ipsilateral IMA graft Aortic root angulation Approach Left Subclavian / Axillary Right Subclavian / Axillary Iliofemoral Aortic Root Angle* >70° >30° * Aortic root angle = angle between plane of aortic valve annulus and horizontal plane

4 Room Setup O1 O2 Option A Option B OR Key: O1 = Operator 1

5 Clinical Data Baseline Characteristics Procedural Outcomes
Mid/Long-Term Outcomes Subclavian vs. Transfemoral

6 Clinical Data Baseline Characteristics Procedural Outcomes
Mid/Long-Term Outcomes Subclavian vs. Transfemoral

7 Procedure Success Subclavian
1. Petronio AS. Italian Experience Subclavian vs. Transfemoral. Presented at TCT Laborde JC. TAVR Access Site Considerations. Presented at TVT Verkroost MWA. TAVI Using Left Subclavian Route. Presented at TCT Modine T. TAVI using Axillary/subclavian Access. J Thorac Cardiovasc Surg. 2011; 141(2). Note: Procedure success definition varies among publications

8 Clinical Data Baseline Characteristics Procedural Outcomes
Mid/Long-Term Outcomes Subclavian vs. Transfemoral

9 30-Day Survival Subclavian
1. Petronio AS. Italian Experience Subclavian vs. Transfemoral. Presented at TCT Gilard M. France 2 Registry. Presented at TCT Blackman D. UK Registry Comparison valve type and access approach. Presented at TCT Verkroost MWA. TAVI Using Left Subclavian Route. Presented at TCT Modine T. TAVI using Axillary/subclavian Access. J Thorac Cardiovasc Surg. 2011; 141(2).

10 Long-term Survival Subclavian
1. Blackman D. UK Registry Comparison valve type and access approach. Presented at TCT Petronio AS. Italian Experience Subclavian vs. Transfemoral. Presented at TCT 2011

11 Clinical Data Baseline Characteristics Procedural Outcomes
Mid/Long-Term Outcomes Subclavian vs. Transfemoral

12 Anna Sonia Petronio MD, FESC University of Pisa, Italy
CoreValve Subclavian: A Single Center Propensity-Case-Controlled Registry of Transcatheter Aortic Valve Implantation via Subclavian vs. Transfemoral Access Anna Sonia Petronio MD, FESC University of Pisa, Italy Petronio AS. Italian Experience Subclavian vs. Transfemoral. Presented at TCT 2011

13 Propensity Score Matching
Propensity score matching was performed in order to derive a comparable group of transfemoral patients 141 TAVR Trans-subclavian 141 TARI Trans-femoral matched PAD 85% 21% P<0.0001 The propensity score was calculated for each patient using a logistic regression model which included the following variables: CAD Diabetes Pulmonary Hypertension Prior aortic Valvuloplasty Prior pulmonary edema Prior stroke LVEF Chronic renal failure Fragility To account fo potential differeences between transfemoral and trans-subclavian TAVI regarding the main clinical predictors of procedural success a propensity analysis was performed. Petronio AS. Italian Experience Subclavian vs. Transfemoral. Presented at TCT 2011

14 Results Overall Survival – 2 years (A.S.Petronio et al. TCT 2011)

15 Conclusions Subclavian access is safe and effective
First alternative access route to PAD Reduced distance to aortic valve results in more direct catheter response Similar acute and 2-year results compared to femoral approach Less bleeding complications

16 Thank you CRuiz@NSHS.edu

17 CoreValve® System Subclavian Clinical Experience
Study Subclavian Study Size Number of Centers Follow-up Italian Experience1 141 8 2 years France II Registry2 120 33 6 months UK Registry3 91 6 1 year Italian Registry4 88 12 Netherlands Experience5 22 1 30-days French Experience6 17 4 Key Message: The CoreValve® System has significant global experience, and more than patients have been studied in independent registries. 1. Petronio AS. Italian Experience Subclavian vs. Transfemoral. Presented at TCT Gilard M. France 2 Registry. Presented at TCT Blackman D. UK Registry Comparison valve type and access approach. Presented at TCT Laborde JC. TAVR Access Site Considerations. Presented at TVT Verkroost MWA. TAVI Using Left Subclavian Route. Presented at TCT Modine T. TAVI using Axillary/subclavian Access. J Thorac Cardiovasc Surg. 2011; 141(2).


Download ppt "TAVR Medtronic CoreValve® Subclavian Approach Clinical Data"

Similar presentations


Ads by Google